BISCAGLIA, Simone
 Distribuzione geografica
Continente #
NA - Nord America 10.277
AS - Asia 7.108
EU - Europa 3.631
SA - Sud America 1.219
AF - Africa 176
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 22.456
Nazione #
US - Stati Uniti d'America 9.960
SG - Singapore 2.798
CN - Cina 1.535
BR - Brasile 953
VN - Vietnam 872
DE - Germania 744
IT - Italia 654
HK - Hong Kong 565
FI - Finlandia 394
GB - Regno Unito 379
FR - Francia 350
JP - Giappone 224
IN - India 214
TR - Turchia 212
PL - Polonia 210
UA - Ucraina 163
SE - Svezia 162
RU - Federazione Russa 159
ID - Indonesia 143
MX - Messico 137
CA - Canada 136
BD - Bangladesh 104
AR - Argentina 94
NL - Olanda 87
ZA - Sudafrica 79
ES - Italia 77
IQ - Iraq 64
CO - Colombia 44
PK - Pakistan 43
EC - Ecuador 41
AU - Australia 40
BE - Belgio 37
AT - Austria 36
KR - Corea 36
PH - Filippine 35
MY - Malesia 29
LT - Lituania 28
UZ - Uzbekistan 27
SA - Arabia Saudita 26
VE - Venezuela 26
EG - Egitto 25
IR - Iran 25
CH - Svizzera 22
CZ - Repubblica Ceca 17
IE - Irlanda 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
MA - Marocco 15
TH - Thailandia 15
KE - Kenya 14
PY - Paraguay 12
TW - Taiwan 12
UY - Uruguay 12
IL - Israele 11
JO - Giordania 11
PE - Perù 11
PT - Portogallo 11
HR - Croazia 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
NP - Nepal 9
PS - Palestinian Territory 9
AL - Albania 8
DZ - Algeria 8
TN - Tunisia 8
CY - Cipro 7
DK - Danimarca 7
LB - Libano 7
NO - Norvegia 7
PA - Panama 7
RO - Romania 7
BH - Bahrain 6
CR - Costa Rica 6
ET - Etiopia 6
JM - Giamaica 6
KG - Kirghizistan 6
KW - Kuwait 6
MT - Malta 6
AZ - Azerbaigian 5
GE - Georgia 5
LV - Lettonia 5
SN - Senegal 5
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GY - Guiana 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
HN - Honduras 3
HU - Ungheria 3
LI - Liechtenstein 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 22.414
Città #
Singapore 1.687
Ashburn 1.625
San Jose 916
Fairfield 754
Woodbridge 562
Hong Kong 540
Beijing 486
Santa Clara 457
Houston 442
Munich 441
Chandler 334
Seattle 316
Ann Arbor 298
Wilmington 289
Ho Chi Minh City 288
Cambridge 265
Helsinki 259
Los Angeles 252
Dallas 246
New York 229
Tokyo 207
Warsaw 198
Jacksonville 185
Hanoi 182
Lauterbourg 144
Council Bluffs 141
São Paulo 121
Shanghai 106
Milan 97
Princeton 96
Izmir 95
London 91
Orem 91
Jakarta 86
Ferrara 83
Nanjing 82
Turku 71
Chicago 68
San Diego 67
Mexico City 66
Chennai 57
Atlanta 56
Frankfurt am Main 56
Brooklyn 51
Da Nang 47
Montreal 46
Stockholm 45
Denver 41
Buffalo 40
Johannesburg 40
Mumbai 39
Amsterdam 38
Boston 38
Haiphong 38
Brussels 37
Hefei 37
Nuremberg 37
Manchester 35
Poplar 35
Moscow 33
Boardman 32
Rio de Janeiro 31
Toronto 31
Tianjin 30
Bremen 29
Phoenix 29
Bologna 28
Falls Church 28
San Francisco 27
Salt Lake City 26
Tashkent 24
Ankara 23
Paris 23
The Dalles 23
Nanchang 22
Rome 22
Quito 21
Melbourne 20
New Delhi 20
Redwood City 19
Belo Horizonte 18
Columbus 18
Des Moines 18
Guangzhou 18
Lappeenranta 18
Baghdad 17
Shenyang 17
Shenzhen 17
Washington 17
Biên Hòa 16
Changsha 16
Jiaxing 16
Norwalk 16
Querétaro 16
Schiffdorf 16
Dong Ket 15
Jeddah 15
Redondo Beach 15
Bangkok 14
Cairo 14
Totale 14.644
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 422
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 415
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 365
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 354
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 322
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 301
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 283
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 277
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 277
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 273
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 259
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 258
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 255
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 248
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 246
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 242
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 237
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 235
Uric acid and coronary artery disease: An elusive link deserving further attention 223
Reperfusion Damage - A Story of Success, Failure, and Hope 221
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 216
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 216
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 212
Angina and left ventricular dysfunction: can we "reduce' it? 212
Can we improve myocardial protection during ischaemic injury? 211
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 210
BRS implantation in long lesions requiring device overlapping: Myth or reality? 210
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 209
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 207
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 204
Fractional flow reserve: Current applications and overview of the available data 199
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 199
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 196
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 195
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 191
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 190
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 188
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 188
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 187
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 187
Angina and chronic obstructive pulmonary disease: facing the perfect storm 186
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 179
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 178
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 175
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 172
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 172
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 171
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 171
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 170
Fractional flow reserve implementation in daily clinical practice: A European survey 169
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 169
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 168
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 167
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 166
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 164
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 160
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 160
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 158
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 157
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial 157
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 156
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 152
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 149
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 148
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 147
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 146
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 146
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 144
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 143
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 143
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 142
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 140
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 139
Remodelling after an Infarct: Crosstalk between Life and Death 139
Enhanced stent visualization systems during PCI: A case series and review of literature 139
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 137
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 136
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 133
Functional Assessment and Acute Coronary Syndrome 132
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 132
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 129
Complete vs. culprit-only strategy in older MI patients with multi-vessel disease 127
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 127
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 126
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 125
Seven french radial artery access for PCI: A prospective single-center experience 125
Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction 125
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 124
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 122
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies 120
Complete versus culprit-only strategy in older MI patients with multivessel disease 118
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 118
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 116
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial 114
Multidomain Rehabilitation for Older Patients with Myocardial Infarction 113
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 113
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 112
Combined use of intra-aortic balloon pump and impella in cardiogenic shock: A systematic review 111
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation 111
Totale 18.488
Categoria #
all - tutte 101.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021459 0 0 0 0 0 0 0 0 0 174 192 93
2021/20221.041 106 96 78 43 46 58 56 72 45 78 124 239
2022/2023876 105 55 50 69 128 120 69 72 120 8 58 22
2023/2024899 48 68 36 19 64 147 53 96 23 59 76 210
2024/20254.596 112 104 281 238 507 449 338 270 820 451 565 461
2025/202611.118 1.045 464 1.003 1.403 1.663 764 1.351 717 1.312 1.396 0 0
Totale 22.930